Related Experiment Videos
Association between statin use and Bell's palsy: a population-based study.
Shih-Han Hung1, Li-Hsuan Wang, Herng-Ching Lin
1Department of Otolaryngology, Taipei Medical University Hospital, Taipei, Taiwan.
Drug Safety
|August 1, 2014
Summary
Regular statin use may be linked to an increased risk of Bell
Area of Science:
- Neurology
- Pharmacology
- Epidemiology
Background:
- Statins, HMG-CoA reductase inhibitors, are associated with neurologic disorders.
- Lipid-lowering effects of statins may cause neural toxicity.
Purpose of the Study:
- To investigate the association between statin use and Bell's palsy.
- Utilized a population-based health insurance database for analysis.
Main Methods:
- Case-control study design.
- 1,977 Bell's palsy cases and 5,931 matched controls.
- Conditional logistic regression analysis of prior statin use.
Main Results:
- Statin use was significantly higher in Bell's palsy cases (23.2%) versus controls (16.4%).
- Regular statin use was associated with a 1.46-fold increased odds of Bell's palsy (adjusted OR: 1.46, 95% CI 1.28-1.67).
- Irregular statin use showed no significant association with Bell's palsy.
Conclusions:
- Regular statin use demonstrates a potential association with Bell's palsy.
- Further research may elucidate the underlying mechanisms.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Myasthenia Gravis: Overview and Treatment
3.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.6K
Myocarditis III: Medical Management
342
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
342
Atherosclerosis III: Management
719
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
719
Coronary Artery Disease V: Interprofessional Care
442
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
442
Diphtheria
169
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
169